Compounds > diphenylcyclopropenone
Page last updated: 2024-08-24

diphenylcyclopropenone and Skin Neoplasms

diphenylcyclopropenone has been researched along with Skin Neoplasms in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19902 (8.00)18.7374
1990's0 (0.00)18.2507
2000's4 (16.00)29.6817
2010's14 (56.00)24.3611
2020's5 (20.00)2.80

Authors

AuthorsStudies
Agarwal, A; Estrada, Y; Gulati, N; Han, J; Krueger, JG; Luu, Y; Owji, S; Poplausky, D; Ungar, J; Yassky, D; Young, JN1
Dwyer, L; Frew, JW; Menzies, AM; Pham, JP; Phan, K1
Garioch, J; Lo, MC; Moncrieff, MD1
Bertolli, E; Calsavara, VF; Duprat Neto, JP; Lôbo, MM; Lopes Pinto, CA; Ricci, BV1
Abadir, W; Alavi, N; Look Hong, NJ; Nadler, A; Wright, FC1
Read, T; Schaider, H; Smithers, BM; Soyer, HP; Tan, J; Wagels, M; Webber, S1
Read, T; Schaider, H; Smithers, BM; Soyer, HP; Thomas, J; Wagels, M; Webber, S1
Bertolli, E; Duprat Neto, JP; Gibbons, IL; Macedo, MP; Pinto, CAL; Sonagli, M1
Baum, CL; Jakub, JW; Veverka, KK1
Bullen, A; Byrom, L; Khosrotehrani, K; Polcz, M; Rowe, CJ; Soyer, HP1
Damian, DL; Saw, RP; Thompson, JF1
Fawcett, JM; Kennedy, CT; Newell, EL1
Fadhil, M; Garioch, J; Moncrieff, M1
Aiba, S; Fujimura, T; Furudate, S; Haga, T; Hashimoto, A; Kakizaki, A; Kambayashi, Y1
Carvajal, RD; Gulati, N; Krueger, JG; Postow, MA; Wolchok, JD1
Abadir, W; Look Hong, NJ; Petrella, TM; Wright, FC; Yeung, C1
Damian, DL; Saw, RP; Shannon, KF; Thompson, JF1
Damian, DL; Levis, WR; Martiniuk, F; Scolyer, RA; Tchou-Wong, KM; Thompson, JF1
Damian, DL; Saw, RPM1
Damian, DL; Thompson, JF2
Hengge, UR; Meykadeh, N1
Sterry, W; Trefzer, U1
Harland, CC; Saihan, EM1
Mayerhausen, W; Remy, W1

Reviews

3 review(s) available for diphenylcyclopropenone and Skin Neoplasms

ArticleYear
Efficacy of topical diphencyprone for melanoma in-transit metastases: a systematic review and meta-analysis.
    Melanoma research, 2023, 10-01, Volume: 33, Issue:5

    Topics: Cyclopropanes; Humans; Melanoma; Skin Neoplasms

2023
Response rates of cutaneous melanoma metastases to diphencyprone: A meta-analysis.
    Journal of the American Academy of Dermatology, 2020, Volume: 83, Issue:6

    Topics: Administration, Cutaneous; Cyclopropanes; Haptens; Humans; Melanoma; Skin; Skin Neoplasms; Treatment Outcome

2020
Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma.
    Journal of surgical oncology, 2014, Volume: 109, Issue:4

    Topics: Administration, Topical; Animals; Cyclopropanes; Dermatitis, Contact; Humans; Immunotherapy; Melanoma; Neoplasm Metastasis; Skin Neoplasms

2014

Trials

1 trial(s) available for diphenylcyclopropenone and Skin Neoplasms

ArticleYear
Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study.
    BMJ open, 2017, Oct-06, Volume: 7, Issue:10

    Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Clinical Protocols; Cyclopropanes; Female; Humans; Imiquimod; Immunotherapy; Male; Melanoma; Middle Aged; Pilot Projects; Remission Induction; Research Design; Skin Neoplasms; Treatment Outcome; Young Adult

2017

Other Studies

21 other study(ies) available for diphenylcyclopropenone and Skin Neoplasms

ArticleYear
Proteomic profiling of a patient with cutaneous melanoma metastasis regression following topical contact sensitizer diphencyprone and immune checkpoint inhibitor treatment.
    Scientific reports, 2022, 12-26, Volume: 12, Issue:1

    Topics: Humans; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Melanoma, Cutaneous Malignant; Proteomics; Skin Neoplasms

2022
Sequencing in management of in-transit melanoma metastasis: Diphencyprone versus isolate limb infusion.
    Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2020, Volume: 73, Issue:7

    Topics: Aged; Aged, 80 and over; Chemotherapy, Cancer, Regional Perfusion; Cost of Illness; Cyclopropanes; Disease Progression; Female; Humans; Male; Melanoma; Middle Aged; Retrospective Studies; Skin Neoplasms

2020
Lesional therapies for in-transit melanoma.
    Journal of surgical oncology, 2020, Volume: 122, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclopropanes; Female; Follow-Up Studies; Humans; Imiquimod; Injections, Intralesional; Interleukin-2; Male; Melanoma; Middle Aged; Prognosis; Retrospective Studies; Skin Neoplasms; Survival Rate

2020
Diphenylcyclopropenone for the treatment of cutaneous in-transit melanoma metastases - results of a prospective, non-randomized, single-centre study.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Cyclopropanes; Female; Humans; Male; Melanoma; Middle Aged; Prospective Studies; Skin Neoplasms; Treatment Outcome

2017
Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience.
    Anais brasileiros de dermatologia, 2018, Volume: 93, Issue:2

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Brazil; Cyclopropanes; Female; Humans; Male; Melanoma; Middle Aged; Skin Neoplasms; Treatment Outcome; Young Adult

2018
Responses to Topical Diphenylcyclopropenone as an Adjunct Treatment for In-Transit Melanoma: A Tertiary Referral Center Experience.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2018, Volume: 44, Issue:12

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Cyclopropanes; Disease Progression; Female; Haptens; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Neoplastic Cells, Circulating; Retrospective Studies; Skin Neoplasms; Tertiary Care Centers; Treatment Outcome; Tumor Burden

2018
Level of contact hypersensitivity response to diphencyprone and keratinocyte cancer.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:11

    Topics: Aged; Cyclopropanes; Dermatitis, Contact; Female; Humans; Immunologic Tests; Keratinocytes; Male; Prospective Studies; Skin Neoplasms

2019
Congenital malignant melanoma and cutaneous metastases treated with diphencyprone.
    Clinical and experimental dermatology, 2016, Volume: 41, Issue:2

    Topics: Antineoplastic Agents; Cyclopropanes; Humans; Infant; Male; Melanoma; Orbital Neoplasms; Skin Neoplasms; Treatment Outcome

2016
Topical diphencyprone for the treatment of locoregional intralymphatic melanoma metastases of the skin; the 5-year Norwich experience.
    The British journal of dermatology, 2016, Volume: 174, Issue:5

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Agents; Cyclopropanes; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Prospective Studies; Skin Neoplasms; Treatment Outcome

2016
Contact immunotherapy enhances the therapeutic effects of nivolumab in treating in-transit melanoma: Two cases reports.
    The Journal of dermatology, 2016, Volume: 43, Issue:6

    Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Cyclobutanes; Cyclopropanes; Female; Humans; Immunotherapy; Male; Melanoma; Nivolumab; Skin Neoplasms

2016
Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment.
    Experimental dermatology, 2016, Volume: 25, Issue:7

    Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Cyclopropanes; Drug Therapy, Combination; Humans; Male; Melanoma; Skin Neoplasms

2016
Topical immunotherapy with diphencyprone (DPCP) for in-transit and unresectable cutaneous melanoma lesions: an inaugural Canadian series.
    Expert review of clinical immunology, 2017, Volume: 13, Issue:4

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Canada; Cyclopropanes; Female; Follow-Up Studies; Humans; Immunization; Immunotherapy; Male; Melanoma; Middle Aged; Quality of Life; Retrospective Studies; Skin; Skin Neoplasms; Treatment Outcome

2017
Topical diphencyprone immunotherapy for cutaneous metastatic melanoma.
    The Australasian journal of dermatology, 2009, Volume: 50, Issue:4

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Agents; Cyclopropanes; Humans; Male; Melanoma; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome

2009
TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone.
    Journal of drugs in dermatology : JDD, 2010, Volume: 9, Issue:11

    Topics: Administration, Topical; Aged; Antigens, CD; CTLA-4 Antigen; Cyclopropanes; Haptens; Humans; Interleukin-17; Kruppel-Like Transcription Factors; Male; Melanoma; Ointments; Promyelocytic Leukemia Zinc Finger Protein; Reverse Transcriptase Polymerase Chain Reaction; Scalp; Skin Neoplasms; Th17 Cells

2010
Dramatic regression of cutaneous, nodal, and visceral melanoma metastases.
    Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:3

    Topics: Adjuvants, Immunologic; Aged, 80 and over; Anti-Infective Agents, Local; Cyclopropanes; Humans; Immunotherapy; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Silver Sulfadiazine; Skin Neoplasms

2011
Topical diphencyprone immunotherapy for a large primary melanoma on an elderly leg.
    American journal of clinical dermatology, 2011, Dec-01, Volume: 12, Issue:6

    Topics: Administration, Cutaneous; Aged, 80 and over; Cyclopropanes; Humans; Immunotherapy; Male; Melanoma; Skin Neoplasms; Treatment Outcome

2011
[Topical immunomodulators in dermatology].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:7

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts

2003
Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma.
    Dermatology (Basel, Switzerland), 2005, Volume: 211, Issue:4

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclopropanes; Dacarbazine; Dose Fractionation, Radiation; Follow-Up Studies; Humans; Injections, Intravenous; Male; Melanoma; Radiotherapy, Adjuvant; Skin Neoplasms

2005
Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone.
    Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:5

    Topics: Administration, Topical; Aged; Antineoplastic Agents; Cyclopropanes; Humans; Male; Melanoma; Neoplasm Recurrence, Local; Skin Neoplasms

2007
Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine.
    Lancet (London, England), 1989, Aug-19, Volume: 2, Issue:8660

    Topics: Administration, Oral; Administration, Topical; Aged; Cimetidine; Cyclopropanes; Drug Administration Schedule; Female; Humans; Melanoma; Skin Neoplasms

1989
[Testing of cellular immune reactivity in melanoma patients with diphenylcyclopropenone in comparison to dinitrochlorobenzol].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1987, Volume: 38, Issue:8

    Topics: Cyclopropanes; Dinitrochlorobenzene; Humans; Immune Tolerance; Immunity, Cellular; Melanoma; Patch Tests; Skin Neoplasms

1987